| ||
| A Phase II Study of Eloxatin and Alimta in Combination With ... Condition: Non-small Cell Lung Cancer Intervention: Drug: Bevacizumab, Oxaliplatin, Pemetrexed Sponsors: Veeda Oncology; Sanofi-Aventis; Eli Lilly and Company; Genentech Completed – verified August 2008 ... Lung Cancer Treatment - http://lungcancertreatment.org/ |
| ||
| New Territory: Surgical Salvage for Stereotactic Body Radiat ... The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? ... journals.lww.com/.../New_Territory__Surgical_Salvage_for_S... |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment